Hsing-Pang Hsieh

Taipei, Taiwan

Hsing-Pang Hsieh

USPTO Granted Patents = 19 


 

Average Co-Inventor Count = 3.4

ph-index = 9

Forward Citations = 234(Granted Patents)


Location History:

  • Taipei, TW (1997 - 2014)
  • Zhunan, TW (2014)
  • Miaoli County, TW (2011 - 2024)

Company Filing History:


Years Active: 1997-2025

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Hsing-Pang Hsieh**

Introduction

Hsing-Pang Hsieh is a notable inventor based in Taipei, Taiwan, recognized for his contributions to pharmaceutical science through a series of groundbreaking patents. With a total of 19 patents to his name, Hsieh's work focuses on enhancing drug formulations and stability, pushing the boundaries of contemporary medicine.

Latest Patents

Among Hsieh's recent innovations is a patent describing crystalline forms of (S, E)-4-(dimethylamino)-N-(3-(4-(2-hydroxy-1-phenylethylamino)-6-phenylfuro[2,3-d]pyrimidin-5-yl)phenyl)but-2-enamide free base, also known as ABT-101. This invention details specific crystalline forms that exhibit unexpected stability and improved pharmacokinetic properties, positioning ABT-101 as a promising candidate for drug development. The pharmaceutical composition and capsule comprising this compound aim to meet bioavailability and drug efficacy standards, representing a significant advancement in therapeutic applications.

Additionally, Hsieh has developed a method for preparing fused multicyclic compounds, which is a manufacturing process designed to produce these compounds on a multikilogram scale effectively. This method enhances efficiency and scalability in pharmaceutical production.

Career Highlights

Hsing-Pang Hsieh has collaborated with esteemed institutions including the National Health Research Institutes and Taipei Medical University. His work in these organizations has significantly contributed to the field of medicine and drug development, ensuring a strong impact on healthcare practices.

Collaborations

Throughout his career, Hsieh has partnered with various researchers, including notable coworkers Yu-Sheng Chao and Jang-Yang Chang. These collaborations have fostered an environment of innovation and have propelled projects that address complex medical challenges.

Conclusion

In conclusion, Hsing-Pang Hsieh's impressive portfolio of patents and collaborations underscores his influence in the pharmaceutical industry. His innovations not only advance drug formulations but also pave the way for improved treatment options, highlighting the essential role inventors play in shaping the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…